Scienion new collaboration
Scienion’s sciFLEXARRAYER S11 to be used by Courtagen for the production of QPDx® Biochips
SCIENION US, Inc. today announced that Courtagen Life Sciences, Inc. – a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry – will use SCIENION’s sciFLEXARRAYER technology to produce innovative biochips for multiplex immunoassays, and collaborate with Scienion to meet future manufacturing and market needs.
“With its novel protein immunoassay platform, QPDx® BioChip, Courtagen has brought a fantastic product to market which has already proven to be successful for biomarker analysis in a variety of applications. We are very pleased that Courtagen, with its highly experienced team, has decided to use our sciFLEXARRAYER S11 to produce these biochips”, said Dr. Holger Eickhoff, Chief Executive Officer of SCIENION AG. “And with our new US subsidiary SCIENION US, Inc. we are well prepared to provide great service and extend the collaboration according to future needs of our new customer.”
Courtagen Life Sciences, Inc. has developed an automated immunoassay system that consists of a self-contained array-based QPDx® BioChip and the Avantra® Q400 Biomarker Workstation. The system provides a simple and robust solution to the need to translate proteomics discoveries into a clinical setting. The self-contained BioChip, one step operation, and short time to results make this technology ideally suited for testing at the point of sample collection, enabling real-time application of biomarker results. The Avantra Q400 is a compact bench top instrument suitable for space limited areas enabling multiplex biomarker analysis for research use only (RUO) at the lab bench or clinical trial site.
“We have been looking for a reliable solution for the reproducible high throughput production of spotted arrays for our QPDx® BioChips,” said Dr. Kate Sheldon, Ph.D., Director of Product Development at Courtagen. “The SCIENION sciFLEXARRAYER S11 is able to consistently produce high quality arrays that meet our needs, and has the capacity to meet demand as our business grows.”
Courtagen Life Sciences, Inc.
Elizabeth Holland, Vice President
Most popular news by...
- Fuelling, version 2.0 – ideas in the field of electromobility:
- MagForce AG Receives Further Patent Related to NanoTherm® Therapy: European patent granted for nanoparticle-drug conjugat...
- Physicists let magnetic dipoles interact on the nanoscale for the first time: “Of great technical interest for future ha...
- Snap shots of one of life's central processes: Human Frontier Science Program provides funding of 900,000 US Dollars in su...
- Adlershof Special 28: Renewable Energies: For the future of energy efficiency
- HIGH TECH – LOW EX: For the future of energy eficiency: An interview with Beate Mekiffer, head of this pilot project in ...
- Climate Climbers: Building climatization by a façade greening system in Adlershof
- Nucleus for innovative storage solutions: Approaches for a self-sufficient energy supply
- Tapping into heaven and earth: How renewable energies are utilised in the Technology Park Adlershof
- High-power diode lasers: Technology transfer the Berlin Way: Silke Pflueger, newly appointed member of ILS' Editorial Advi...
- Carmen moderiert in Adlershof: 50 Jahre Deutsches Fernsehballett
- Veränderung in der Geschäftsführung der Adlershof Projekt GmbH: Gerhard W. Steindorf jetzt Geschäftsführer der Tempel...
- Der Schrittmacher: Auch heute, 18 Jahre später, ist Falk Fabich sichtlich engagiert, wenn er von der Neuordnung der Wisse...
- SPEKTRUM ADLERSHOF : Erste Mietfläche übergeben
- Der Mann, der Alfons Zitterbacke war:
- In stürmischen Zeiten:
- German U15 gegründet: HU und 14 weitere Universitäten wollen Forschungsbedingungen verbessern
- Für die moderne Frau bis Größe 50: Adlershofer CITYdirndl hat alles - außer Trachten
- HU-Start-up BetterTec startet Taxi-App BetterTaxi in Berlin: Unkomplizierte Taxibuchung dank Ein-Klick-Bestellung